Fifth Third Bancorp »

Apogee Therapeutics shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.4M 64k 84.17

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Fifth Third Bancorp

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Rtw Investments
Vanguard Capital Management
Henderson Group
Driehaus Capital Management
State Street Corporation
Perceptive Advisors
Paradigm Biocapital Advisors
Affinity Asset Advisors
Geode Capital Management

View all funds holding Apogee Therapeutics